DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award
The FY25 Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) aims to develop or validate clinical outcomes and biomarkers for ALS clinical trials. Projects can focus on specific therapies or ALS subtypes and don't need to apply to all patients. Applicants must focus on either or both of these areas:
Clinical Biomarkers:<…
Summary: The fiscal year 2025 (FY25) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in Amyotrophic Lateral Sclerosis (AL…
Funding Source
Awards & funding
Eligibility
Dates
Supporting links
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers